Background: Vitamin D exerts profound effects on both adaptive and innate immune functions involved in the development and course of autoimmune and inflammatory diseases. As the incidence of vitamin D insufficiency is surprisingly high in the general population, experimental studies have started to investigate whether vitamin D levels (measured as serum 25 hydroxy vitamin D-25[OH]D) are correlated with immune cells and clinical parameters. Purpose: The aim of the present research was to investigate serum vitamin D status in a casecontrol study in children with asthma and to study associations between vitamin D levels and certain immunological parameters. Materials and methods: A case control study of thirty-nine children with clinically controlled asthma was enrolled to assess the relationship between serum vitamin D concentrations and disease activity. Vitamin D was assayed with a radioimmunoassay kit. We evaluated the relationship between vitamin D concentrations and forced vital capacity (FVC), forced expiratory volume in 1 second (FEV 1 ), and the FEV 1 /FVC ratio. Correlations between inflammatory mediators, Th1, Th2, Th17, and regulatory T cells (Treg) and vitamin D were investigated. Results: Only 15.38% of our asthmatic children had a sufficient serum 25(OH)D ($30 ng/mL) whereas 80% of healthy children expressed sufficient levels. Deficient values of vitamin D (,20 ng/mL) were observed in 17 (43.59%) asthmatic patients (14.40 ± 3.30 ng/mL; P = 0.0001). Deficiency was not observed in controls. Th1/Th2 ratio was significantly correlated to 25(OH) D level (r = 0.698; P = 0.0001). A significant negative correlation was observed between serum interleukin-17 and vitamin D levels in young asthmatics (r = −0.617; P = 0.001). A significant correlation was observed between CD25 
Introduction
Vitamin D deficiency is currently associated with asthma. [1] [2] [3] [4] The protective effects of vitamin D in asthma could be attributable to its immunomodulatory properties. 5 Beyond a central role in calcium and bone physiology, vitamin D metabolism, specifically the conversion of 25(OH)D to the active form of vitamin D (1, 25 [OH] 2 D), has effects on epithelial cell, T-cell, B-cell, and dendritic cell functions, which are important for innate and adaptive immunity. 6, 7 Among the vitamin D-stimulated processes that contribute to tolerance are induction of tolerogenic dendritic cells, 7, 8 development of
+ regulatory T (Treg) cells, 7 activation of T-cell and antigen receptor signalling, 8 and elaboration of antiinflammatory cytokines, including interleukin-10 (IL-10). 9 Gene expression profiles of dendritic cells have identified many 1,25(OH) 2 D-regulated transcripts that are central to dendritic cell function. 7 The observation that 1,25(OH) 2 Dtreated human dendritic cells have the capacity to convert CD4 T cells into IL-10-secreting Treg cells and suppress the proliferation of T cells is particularly provocative in light of the clinical importance of CD4 + CD25 + Foxp3 + Treg cells. 10 Vitamin D has the ability to establish homeostasis between regulatory and suppressor T cell functions to modulate inflammatory process as reported by Chambers and Hawrylowicz. 11 The active form of vitamin D, ie, 1,25(OH) 2 D 3 , mediates a shift of antigen-presenting cells (APC) and CD4 + T cells to a less inflammatory profile. 6 Recently, it was shown that 1,25(OH) 2 D 3 significantly increased the secretion of IL-10 and decreased the secretion of IL-6 and IL-17 by immune cells. 1,25(OH) 2 D 3 also increased the expression and biological activity of indoleamine 2,3-dioxygenase, mediating a significant increase in the number of CD4
+ Treg cells.
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The transcriptional characteristics of CD4 + T cells in young asthmatics indicate that Foxp3 (Treg cells) and RORC (Th17) mRNA expression could be associated with the sustained inflammatory process in asthmatics. 12 The aim of our study was to correlate serum vitamin D levels with asthma severity in children, and to correlate vitamin D levels with Th17 and Treg cells.
Materials and methods

Study subjects
Thirty-nine children with asthma (aged 6-16 years), who were diagnosed and classified according to Global Initiative for Asthma (GINA) recommendations 13 and attending the Department of Pediatric Respiratory Disease (Unit Research: Homeostasis and Cell Dysfunction [UR/99/08-40]), A Mami Hospital, Ariana Hospital Tunisia between July 1, 2010 and August 31, 2010, were enrolled in the study during a planned visit. Severity was assessed before treatment. All patients were on regular treatment with inhaled steroids. Control was assessed on clinical and functional criteria. Patients presenting an asthma exacerbation or suffering from comorbidities were excluded from the study. Thirty age and sex-matched children attending pediatric emergency for acute extra respiratory symptoms served as healthy controls (aged 6-16 years, mean 9.2; 20 males). Asthmatic patients were excluded. Children suffering with other chronic diseases were excluded. Selection was made according to clinical criteria. The hospital ethical committee approved the study according to Global Initiative for Asthma guidelines as we recently reported, and the parents and children gave their informed consent. 12, 13 Vitamin D status definitions
Blood withdrawal was performed between July and August, 2010. Immune tests and serum for vitamin D measurement were retrieved at the same time, and cellular assays were performed on the day of blood collection. The collected serum was immediately shielded from direct light and stored at −20°C. At the end of the study, all samples were analyzed simultaneously. Serum concentrations of 25(OH) D were assayed with a radioimmunoassay kit (Dia-Sorin, Stillwater, MN). Vitamin D level values were used as a continuous variable and were categorized in descriptive analyses as desirable (or sufficient) when scores were at least 30 to 40 ng/mL (75 to 100 nmol/L), insufficient between 20 and 30 ng/mL (50 and 75 nmol/L) and deficient when ,20 ng/mL, as previously recommended.
3,14
Lymphocytes subsets T cell phenotyping Lymphocytes were isolated from peripheral blood drawn from 39 asthmatic patients and 30 healthy children. Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll Hypaque gradient centrifugation (Histopaque ® ; Sigma Aldrich, Zwijndrecht, The Netherlands). CD4 + T cells were selectively isolated with RosetteSep ® (Stem Cell Technologies, Grenoble, France). The method for intracellular staining of CD4 + T-cell subsets has been described in detail previously. 15, 16 The following monoclonal antibodies were used: fluorescein isothiocyanate (FITC)-labeled anti-interferon-gamma Cell surface (CD4, CD25) and intracellular (Foxp3) staining was carried out on freshly isolated PBMCs from heparinized blood, as we reported recently. 17 Lymphocytes were gated on the basis of their forward and side scatter properties by using FACSCalibur flow cytometry (Becton Dickinson, San Jose, CA). The data were analyzed using CellQuest software (Becton Dickinson). The following reagents were used: submit your manuscript | www.dovepress.com
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Ficoll and CD4-FITC monoclonal antibody (Sigma Aldrich, St Louis, MO); CD25-PC5 (Immunotech, Marseille, France); Foxp3-PE, clone: PCH101 (eBioscience, San Diego, CA); and an intracellular staining kit (eBioscience).
Plasma cytokines
Plasma IL-17, IL-6, and IL-10 concentrations were measured by enzyme-linked immunosorbent assay (using reagent kits from R&D Systems).
Statistical analysis
Since plasma cytokine concentrations were not in a Gaussian distribution, the Mann-Whitney rank sum test was used to assess the differences in cytokine concentrations in asthmatic patients and control subjects. The Pearson correlation test was used to ascertain the correlation among plasma cytokine concentrations. All analyses were performed using SPSS statistical software for Windows (version 9.0; SPSS Inc, Chicago, IL). A probability of P , 0.05 was considered as significant. Unless otherwise specified, results in the figures are expressed as median (interquartile range: 25th, 75th, 10th and 90th percentiles; the 50th percentile represents the median).
Results
Demographic data on patients and healthy controls
Data of asthmatic patients are depicted in Table 1 . The severity of asthma in this group of patients was presented according to GINA guidelines. The severity of asthma was depicted as mild in 60.5%, moderate in 36.8%, and severe in 2.7%. Considering the low number of severe asthmatics, they were included with moderate asthmatics in the study. No difference was observed in the body weight between asthmatic children (32.7 kg; range: 26-45) and the healthy control group (36.8 kg; range: 29-47).
Vitamin D levels in asthmatic patients and healthy controls
The healthy subjects and asthmatic children do not differ in sex and age. There was no significant difference in mean vitamin D serum levels between healthy controls (23.30 ± 4.57 ng/mL) and patients (20.89 ± 7.51 ng/mL; P = 0.12). However, when patients and controls were divided according to vitamin D classes, significant differences were observed ( Table 2 ). Sufficient vitamin D levels (33.83 ± 3.31 ng/mL; range: 30-38 ng/mL) were observed in six asthmatics (15.38%). Insufficient levels were found in 16 (41%) patients (22.94 ± 2.94% ng/mL; range: 20-29.2 ng/mL), and deficient values (14.40 ± 3.30 ng/mL; range: 9.7-19.7 ng/mL) were observed in 17 patients (43.59%). Healthy controls (n = 30) were either sufficient (80%) (31.83 ± 2.64 ng/mL; range: 30-37 ng/mL) or insufficient (20%) (21.20 ± 1.12 ng/mL; range: 20.8-29.8 ng/mL). No deficiency was observed in the controls.
Vitamin D serum concentrations depending on clinical data
Vitamin D level in asthmatics (sufficient, insufficient, and deficient) was studied according to the disease severity (mild and moderate/severe asthma). Patients with moderate asthma expressed lower vitamin D levels (14.67 ± 3.20 ng/mL) than mild asthmatics did (26.10 ± 5.85 ng/mL; P = 0.0001) ( ). The differences were statistically significant (IL-17: P = 0.001; IL-6: P = 0.002). There was no correlation between serum concentrations of IL-6 and vitamin D levels ( Figure 2A) . A significant negative correlation was observed between IL-17 and vitamin D levels in young asthmatics (r = −0.617; P = 0.001) ( Figure 2B ).
intracellular cytokines Th1 and Th2 in peripheral T helper cells
The percentage of IFN-γ-producing CD4 + Th1 cells was found to be significantly higher in healthy children (20.37% ± 4.4%; range: 10.5%-27%) than in asthmatic patients (6.62% ± 3.46%; range: 2.0%-13.8%; P = 0.0001) ( Figure 3A) . A significant difference was observed in the percentage of IL-4-producing CD4 + Th2 cells between healthy controls (0.92% ± 0.59%; range: 0.33%-1.9%) and asthmatics (0.617% ± 0.35%; range: 0.21%-1.7%; P = 0.0035) ( Figure 3B ). The Th1/Th2 ratios of normal controls were significantly higher (27.26% ± 14.35%; range: 9.5%-27.3%) than those of asthmatic children (13.48% ± 8.55%; range: 2.15%-39.4%; P = 0.0001) ( Figure 3C ). A significant positive correlation was observed between 25(0H)D levels and Th1/Th2 ratios in asthmatic children (r = 0.698; P = 0.0001) ( Figure 3D ). 
Regulatory T cells correlate with vitamin D level
We have recently reported that children with asthma expressed low percentages of Treg cells. 17 The results for the asthmatic subjects in this study were in accord with those reported by Chinellato et al, who found that hypovitaminosis D is frequent in children with asthma who live in a Mediterranean country and that lower levels of vitamin D are associated with reduced asthma control. 2 Vitamin D insufficiency was also reported to be common in a population of North American children with mildto-moderate persistent asthma and is associated with higher odds of severe exacerbation over a 4-year period. + production. Notes: Box and whiskers plot of Tr1-producing cells/Th17-producing cells ratio in asthmatic patients and healthy children. Tr1 and Th17 cytokine were determined by fast immune cytokine system from normal controls (n = 30) and asthmatic patients (n = 39). The medians are indicated by a line inside each box, the 25th and 75th percentiles are indicated by the box limits, and the lower and upper error bars represent the 10th and 90th percentiles, respectively. The mean values were compared and the P values are indicated. [21] [22] [23] The development of certain immune cells requires the expression of VDR both intrinsically and extrinsically as reported by Yu and Cantorna and Maruotti and Cantatore. 24, 25 Recently, the effect of vitamin D on innate immunity-mediated inflammation, enhancing the antimicrobial properties of immune cells, such as monocytes and macrophages, has been demonstrated. 24, 25 In addition, vitamin D directly affects T cell responses by inhibiting the production of Th1 cytokines (IL-2 and IFN-γ), Th17 cyto -kines (IL-17), and by stimulating Th2 cytokine production (IL-4). Moreover, vitamin D influences the maturation of dendritic cells. 22 In asthma, vitamin D could be considered an important mediator, in which fluctuation is correlated to the inflammatory state of the disease.
VDR may function as a regulator of asthma and atopy susceptibility. 26 A strong association between genetic variants at the VDR locus and asthma/atopy in a Quebec cohort was reported. 27 Along with other known asthma risk genes such as ADAM33, 27 TLR, 28 and RANTES, 29 the addition of VDR involvement in the understanding of asthma/atopy pathogenesis will shed light on better control and treatment. VDR-deficient mice failed to develop experimental allergic asthma, suggesting a role for vitamin D in driving Th2 inflammation in the airways. 30 In asthmatic patients, T cells and particularly CD4 + lymphocytes are stimulated and switch from naïve to memory CD4 + T cells. 7 The decreased level of vitamin D in asthma could be explained in part by CD4 cells consuming intrinsic vitamin D during their activation, as VDR expression on CD4 + T lymphocytes increases drastically after cell activation. 23 Addition of 1,25(OH) 2 D 3 leads to decreased secretion of IL-2 and IFN-γ by CD4 T cells and promotes IL-5 and IL-10 production, which further shifts the T cell response towards Th2 dominance. 23, 24 Importantly, immune cells are able to activate vitamin D locally, which indicates an autocrine or paracrine role for this vitamin within the immune system.
Lower levels of vitamin D in children were associated with increased markers of asthma severity. 4 Several studies have reported associations of low vitamin D status with poor pulmonary function and increased incidence of respiratory infections, asthma, and chronic obstructive pulmonary disease. 6 Mechanistic studies suggested that 1,25-(OH) 2 D 3 influenced downregulation of the glucocorticoid receptor by its ligand. 31, 32 These studies suggest that vitamin D may have therapeutic potential in severe asthma patients as a steroid-enhancing agent. Emerging studies show an association between low vitamin D status and poor clinical responsiveness to glucocorticoids in asthma patients. 33 If a steroid-enhancing role for vitamin D is proven, it is likely to be applicable to other chronic illness in which steroids represent a primary treatment, as also suggested by data on animal models. 32 Nevertheless, considerable interest remains in the therapeutic application of vitamin D to asthma, and examples of beneficial effects exist.
The fact that Th1/Th2 ratio and Th17 were correlated to serum vitamin D raises a question about the origin of vitamin D deficiency in asthma. More studies are needed to clarify the mechanisms by which vitamin D regulates cellular immunity. Similarly, the genetic factors influencing 1,25(OH) 2 D 3 production and vitamin D receptor expression should be explored. The microbial pattern-recognition receptor known as Toll-like receptor 9 (TLR9) was described as a biomarker of vitamin D-induced IL-10 + Tregs. Ligation of TLR9 with its agonist CpG (cytosine-phosphate-guanine) oligonucleotide turned off IL-10 production, suggesting a control mechanism abrogating Treg. 33, 34 The active form of vitamin D influences innate and adaptive immunity. It acts on APCs and T cells to promote peripheral tolerance through the inhibition of inflammatory responses and the induction of Treg cells. Recently, Wong et al reported that a coculture of bronchial epithelial cells and basophils could significantly induce the release of IL-6, an epithelial inflammatory cytokine as well as CCL2, a chemokine for basophils, eosinophils, and monocytes. 35 This induction was synergistically enhanced by IL-17A. The interaction of basophils and bronchial epithelial cells was under IL-17A stimulation. It was differentially regulated by extracellular signal-regulated kinase, c-Jun N-terminal protein kinase, p38 mitogen-activated protein kinase, and nuclear factor-κB pathways. These findings suggest a new immunopathological role of Th17 cells and basophils in allergic asthma. 35 Recently, Baeke et al reported that TX527 (hypocalcemic vitamin D analogs) directly affects human T cell function, thereby inhibiting effector T cell reactivity while inducing regulatory T cell characteristics, imprinting them with a specific homing signature favoring migration to sites of inflammation. 36 These findings confirmed that vitamin D is an important regulator of immune function. T cells express the vitamin D receptor and have been shown to be direct and indirect vitamin D targets. 37 Cantorna 37 suggested that the expression of VDR is required for the development of two cell types, NKT cells and CD8αα T cells, which inhibit autoimmunity. In addition, effector T cell cytokine production is regulated by vitamin D.
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The available evidence suggests that NKT and CD8αα T cells express VDR as part of the selection process to protect against the generation of autoimmunity.
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Conclusion
Our study provides important information on vitamin D levels in asthmatic children in the Mediterranean region. We were able to show that vitamin D deficiency in asthmatic patients is common, and it is similar to that seen in the autoimmune diseases. We found significant correlations between several inflammatory and immunological markers and vitamin D levels. These findings should be confirmed prospectively through the generation of an efficient multivariate model allowing further research about the use of vitamin D supplementation in patients with asthma.
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